{"id":"W2122397603","doi":"10.1007/978-1-60761-524-8_10","title":"Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer","year":2010,"lang":"en","type":"book-chapter","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Erlotinib; Gefitinib; Cetuximab; Medicine; Epidermal growth factor receptor; Docetaxel; Lung cancer; Oncology; Bevacizumab; Erlotinib Hydrochloride; Internal medicine; Chemotherapy; Clinical trial; EGFR inhibitors; Monoclonal antibody; Tyrosine kinase; Pharmacology; Cancer research; Cancer; Immunology; Receptor; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001896841,0.0005599436,0.0003492309,0.000660874,0.0001649803,0.0005595733,0.0003637234,0.0005338368,0.01047044],"category_scores_gemma":[0.0001879382,0.0001145714,0.0001800828,0.0007037923,0.0001732161,0.0007505507,0.0003464876,0.001428372,0.01013422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004360839,"about_ca_system_score_gemma":0.0004256189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006228452,"about_ca_topic_score_gemma":0.002923825,"domain_scores_codex":[0.9999204,0.00001237537,0.000004190454,0.000008151927,0.00004906111,0.000005854576],"domain_scores_gemma":[0.9999465,0.00002360822,0.000005356449,0.000002023717,0.00001260439,0.000009864259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005293193,0.0000857662,0.00008769457,0.0007078669,0.0000091876,0.0001596206,0.00008031244,0.0003838,0.001804457,0.007948867,0.4041003,0.5845793],"study_design_scores_gemma":[0.000008945244,0.00002749798,0.0002515254,0.0001870715,0.000004053072,0.0004944815,0.00001167731,0.00008090127,0.0001769561,0.001828068,0.9969257,0.000003352912],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001202875,0.7863968,0.002096816,0.006302662,0.004917757,0.00005992366,0.0001752174,0.0001706908,0.1986773],"genre_scores_gemma":[0.006927427,0.6208647,0.004128505,0.005904584,0.003043395,0.00006667514,0.000330157,0.00005890085,0.3586756],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01047044,"threshold_uncertainty_score":0.03502715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01444095198798569,"score_gpt":0.3087034878413512,"score_spread":0.2942625358533655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}